Biomarker guidance in selection among breakthrough treatment options in advanced and recurrent endometrial cancer
Gespeichert in:
| Veröffentlicht in: | Gynecologic oncology 2024-08, Vol.187, p.249-252 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 252 |
|---|---|
| container_issue | |
| container_start_page | 249 |
| container_title | Gynecologic oncology |
| container_volume | 187 |
| creator | Chan, John K. Tewari, Krishnansu Monk, Bradley J. Herzog, Thomas J. Coleman, Robert L. Richardson, Michael T. Kapp, Daniel S. Francoeur, Alex A. |
| description | |
| doi_str_mv | 10.1016/j.ygyno.2024.05.022 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3065274358</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0090825824002415</els_id><sourcerecordid>3065274358</sourcerecordid><originalsourceid>FETCH-LOGICAL-c239t-a413bfe5683b186165d78820027508db8d46f634ba7c5e6cb4933a75f72a06c83</originalsourceid><addsrcrecordid>eNp9kMFu1DAQhi0EokvhCZCQj1wSxnbsOAcOUAGtVIkLnC3Hnmy9TeytnVTat2_CFo6cRiN9__yaj5D3DGoGTH061Kf9KaaaA29qkDVw_oLsGHSyUlp2L8kOoINKc6kvyJtSDgAggPHX5EJoLXQjuh15-BrSZPM9ZrpfgrfRIQ2RFhzRzSFFaqcU97TPaO_nu5yW_R2d12WeMM40HTembAnrH7ewpzZ6mtEtOW8ERp8mnHOwI3UbkN-SV4MdC757npfk9_dvv66uq9ufP26uvtxWjoturmzDRD-gVFr0TCumpG-15gC8laB9r32jBiWa3rZOonJ90wlhWzm03IJyWlySj-e7x5weFiyzmUJxOI42YlqKEaAkbxshN1ScUZdTKRkHc8xhtXIyDMzm2hzMH9dmc21AmtX1mvrwXLD0E_p_mb9yV-DzGcD1zceA2RQXcJMUVkGz8Sn8t-AJc8KTAg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3065274358</pqid></control><display><type>article</type><title>Biomarker guidance in selection among breakthrough treatment options in advanced and recurrent endometrial cancer</title><source>Elsevier ScienceDirect Journals Complete</source><creator>Chan, John K. ; Tewari, Krishnansu ; Monk, Bradley J. ; Herzog, Thomas J. ; Coleman, Robert L. ; Richardson, Michael T. ; Kapp, Daniel S. ; Francoeur, Alex A.</creator><creatorcontrib>Chan, John K. ; Tewari, Krishnansu ; Monk, Bradley J. ; Herzog, Thomas J. ; Coleman, Robert L. ; Richardson, Michael T. ; Kapp, Daniel S. ; Francoeur, Alex A.</creatorcontrib><identifier>ISSN: 0090-8258</identifier><identifier>ISSN: 1095-6859</identifier><identifier>EISSN: 1095-6859</identifier><identifier>DOI: 10.1016/j.ygyno.2024.05.022</identifier><identifier>PMID: 38838439</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><ispartof>Gynecologic oncology, 2024-08, Vol.187, p.249-252</ispartof><rights>2024</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c239t-a413bfe5683b186165d78820027508db8d46f634ba7c5e6cb4933a75f72a06c83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ygyno.2024.05.022$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38838439$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chan, John K.</creatorcontrib><creatorcontrib>Tewari, Krishnansu</creatorcontrib><creatorcontrib>Monk, Bradley J.</creatorcontrib><creatorcontrib>Herzog, Thomas J.</creatorcontrib><creatorcontrib>Coleman, Robert L.</creatorcontrib><creatorcontrib>Richardson, Michael T.</creatorcontrib><creatorcontrib>Kapp, Daniel S.</creatorcontrib><creatorcontrib>Francoeur, Alex A.</creatorcontrib><title>Biomarker guidance in selection among breakthrough treatment options in advanced and recurrent endometrial cancer</title><title>Gynecologic oncology</title><addtitle>Gynecol Oncol</addtitle><issn>0090-8258</issn><issn>1095-6859</issn><issn>1095-6859</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kMFu1DAQhi0EokvhCZCQj1wSxnbsOAcOUAGtVIkLnC3Hnmy9TeytnVTat2_CFo6cRiN9__yaj5D3DGoGTH061Kf9KaaaA29qkDVw_oLsGHSyUlp2L8kOoINKc6kvyJtSDgAggPHX5EJoLXQjuh15-BrSZPM9ZrpfgrfRIQ2RFhzRzSFFaqcU97TPaO_nu5yW_R2d12WeMM40HTembAnrH7ewpzZ6mtEtOW8ERp8mnHOwI3UbkN-SV4MdC757npfk9_dvv66uq9ufP26uvtxWjoturmzDRD-gVFr0TCumpG-15gC8laB9r32jBiWa3rZOonJ90wlhWzm03IJyWlySj-e7x5weFiyzmUJxOI42YlqKEaAkbxshN1ScUZdTKRkHc8xhtXIyDMzm2hzMH9dmc21AmtX1mvrwXLD0E_p_mb9yV-DzGcD1zceA2RQXcJMUVkGz8Sn8t-AJc8KTAg</recordid><startdate>20240801</startdate><enddate>20240801</enddate><creator>Chan, John K.</creator><creator>Tewari, Krishnansu</creator><creator>Monk, Bradley J.</creator><creator>Herzog, Thomas J.</creator><creator>Coleman, Robert L.</creator><creator>Richardson, Michael T.</creator><creator>Kapp, Daniel S.</creator><creator>Francoeur, Alex A.</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20240801</creationdate><title>Biomarker guidance in selection among breakthrough treatment options in advanced and recurrent endometrial cancer</title><author>Chan, John K. ; Tewari, Krishnansu ; Monk, Bradley J. ; Herzog, Thomas J. ; Coleman, Robert L. ; Richardson, Michael T. ; Kapp, Daniel S. ; Francoeur, Alex A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c239t-a413bfe5683b186165d78820027508db8d46f634ba7c5e6cb4933a75f72a06c83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chan, John K.</creatorcontrib><creatorcontrib>Tewari, Krishnansu</creatorcontrib><creatorcontrib>Monk, Bradley J.</creatorcontrib><creatorcontrib>Herzog, Thomas J.</creatorcontrib><creatorcontrib>Coleman, Robert L.</creatorcontrib><creatorcontrib>Richardson, Michael T.</creatorcontrib><creatorcontrib>Kapp, Daniel S.</creatorcontrib><creatorcontrib>Francoeur, Alex A.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Gynecologic oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chan, John K.</au><au>Tewari, Krishnansu</au><au>Monk, Bradley J.</au><au>Herzog, Thomas J.</au><au>Coleman, Robert L.</au><au>Richardson, Michael T.</au><au>Kapp, Daniel S.</au><au>Francoeur, Alex A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Biomarker guidance in selection among breakthrough treatment options in advanced and recurrent endometrial cancer</atitle><jtitle>Gynecologic oncology</jtitle><addtitle>Gynecol Oncol</addtitle><date>2024-08-01</date><risdate>2024</risdate><volume>187</volume><spage>249</spage><epage>252</epage><pages>249-252</pages><issn>0090-8258</issn><issn>1095-6859</issn><eissn>1095-6859</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>38838439</pmid><doi>10.1016/j.ygyno.2024.05.022</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0090-8258 |
| ispartof | Gynecologic oncology, 2024-08, Vol.187, p.249-252 |
| issn | 0090-8258 1095-6859 1095-6859 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_3065274358 |
| source | Elsevier ScienceDirect Journals Complete |
| title | Biomarker guidance in selection among breakthrough treatment options in advanced and recurrent endometrial cancer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T20%3A05%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Biomarker%20guidance%20in%20selection%20among%20breakthrough%20treatment%20options%20in%20advanced%20and%20recurrent%20endometrial%20cancer&rft.jtitle=Gynecologic%20oncology&rft.au=Chan,%20John%20K.&rft.date=2024-08-01&rft.volume=187&rft.spage=249&rft.epage=252&rft.pages=249-252&rft.issn=0090-8258&rft.eissn=1095-6859&rft_id=info:doi/10.1016/j.ygyno.2024.05.022&rft_dat=%3Cproquest_cross%3E3065274358%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3065274358&rft_id=info:pmid/38838439&rft_els_id=S0090825824002415&rfr_iscdi=true |